Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 11 of 13 for:    VM202

Hepatocyte Growth Factor to Improve Functioning in PAD (HI-PAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03363165
Recruitment Status : Recruiting
First Posted : December 6, 2017
Last Update Posted : August 20, 2019
National Institute on Aging (NIA)
Helixmith Co., Ltd.
Information provided by (Responsible Party):
Mary McDermott, Northwestern University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2021